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Abstract
Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are emerging in southeast Queensland, Australia,
but the incidence of carriage of CA-MRSA strains is unknown. The aim of this study was to assess the nasal carriage rate of S. aureus,
including CA-MRSA strains, in the general adult population of southeast Queensland. 396 patients presenting to general practices in
two Brisbane suburbs and 303 volunteers randomly selected from the electoral rolls in the same suburbs completed a medical question-
naire and had nasal swabs performed for S. aureus. All isolates of S. aureus underwent antibiotic susceptibility testing and single-nucleo-
tide polymorphism (SNP) and binary typing, including determination of Panton–Valentine leukocidin (PVL). The nasal carriage rate of
methicillin-susceptible S. aureus (MSSA) was 202/699 (28%), a rate similar to that found in other community-based nasal carriage studies.
According to multivariate analysis, nasal carriage of S. aureus was associated with male sex, young adult age group and Caucasian ethnic-
ity. Only two study isolates (one MSSA and one CA-MRSA) carried PVL. The nasal carriage rate of MRSA was low, at 5/699 (0.7%), and
only two study participants (0.3%) had CA-MRSA strains. CA-MRSA is an emerging cause of infection in southeast Queensland, but as
yet the incidence of carriage of CA-MRSA in the general community is low.
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Introduction
Community-associated methicillin-resistant Staphylococcus aur-
eus (CA-MRSA) is an emerging cause of infection worldwide
[1]. In Australia, it was ﬁrst reported from a small Aboriginal
community in 1993 [2], and since then the infection has
emerged throughout Australia, with most isolates of CA-
MRSA being non-multiresistant (deﬁned as S. aureus resistant
to two or fewer non-b-lactam antibiotics) (NM-MRSA) [3].
Brisbane, the capital city of the state of Queensland, has the
second highest prevalence of CA-MRSA of all the Australian
state capital cities, with CA-MRSA strains comprising 13% of
clinical isolates of S. aureus collected in an outpatient setting
in Brisbane in 2004, an increase from 5% in 2000 [3]. The
most common clinical manifestation of CA-MRSA infection is
skin and soft tissue infection, which occurs in more than
90% of patients [4], but more serious infections, e.g. bacte-
raemias and necrotizing pneumonias, also occur, particularly
in young adults [5]. Many strains of CA-MRSA carry the viru-
lence factor Panton–Valentine leukocidin (PVL), and the inci-
dence of PVL in clinical isolates of S. aureus in southeast
Queensland is 55% for NM-MRSA and 16% for methicillin-
susceptible S. aureus (MSSA) [4], a relatively high percentage
of PVL carriage for MSSA in comparison to other studies
[6]. The most common strain of CA-MRSA in Brisbane is
the ST93 Queensland strain (usually PVL-positive), which
was ﬁrst isolated in 2000, but other common strains include
the ST30 southwest Paciﬁc strain (usually PVL-positive) and
ST1 WA-MRSA-1 (usually PVL-negative) [3,7]. In our
recently published clinical study of S. aureus, more than half
of the NM-MRSA strains were one of these three strains [4].
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The most common site for S. aureus carriage is the nose [8],
and nasal carriage of CA-MRSA strains is associated with a
much higher incidence of clinical infection than that of other
strains of S. aureus. Soldiers who were nasal carriers of CA-
MRSA strains had a 38% risk of developing clinical infection
with the same strain of S. aureus when followed longitudinally
over an 8–10-week period, a 10.7-fold greater risk than nasal
carriers of MSSA strains [9]. Studies of the carriage rates of
CA-MRSA strains in Australia are lacking. Children in a rela-
tively small, predominantly indigenous Queensland commu-
nity had high rates of both skin infection and nasal carriage
of CA-MRSA strains [10]. However, there have been no
studies of CA-MRSA carriage performed in the general Aus-
tralian adult population. The primary aim of this study was
to assess the nasal carriage rate of S. aureus, including CA-
MRSA strains, in adult volunteers in Brisbane. Secondary
aims included assessment of the population structure of car-
riage strains of S. aureus and the prevalence of selected viru-
lence factors, including PVL.
Materials and Methods
The study was performed in volunteer adult populations
(aged 18 years or older) in two Brisbane suburbs, Inala and
Carindale, between July 2005 and March 2006. These suburbs
were chosen because Inala has large populations of Aboriginal
and Torres Strait Islanders and Polynesians [11], two ethnic
groups known to have a high rate of CA-MRSA infections
[7,12], whereas Carindale, in contrast, does not. Three hun-
dred and ninety-six patients who presented with non-infec-
tious conditions to a general practice in each suburb
completed a one-page medical questionnaire and had swabs
taken from the anterior nares, which were used to culture
for S. aureus on horse blood agar. Three hundred and three
volunteers randomly selected from the Australian electoral
roll for the suburbs of Inala and Carindale completed a similar
questionnaire and underwent nasal swabbing. All participants
were assessed as to the presence or absence of healthcare-
associated risk factors. These were deﬁned as hospitalization,
surgery, dialysis, residence in a long-term-care facility (nursing
home, hostel or prison) or employment in a healthcare occu-
pation in the previous 12 months, known MRSA infection or
colonization in the last 12 months, or the presence of a per-
manent indwelling catheter or percutaneous or invasive medi-
cal device (e.g. tracheostomy tube, gastrostomy tube, Foley
catheter) at the time of culture [13]. CA-MRSA was deﬁned
as MRSA isolated from patients without the above-mentioned
healthcare-associated risk factors. The study was performed
prior to the proposed new deﬁnition of CA-MRSA by Millar
et al. [14], but the deﬁnition of CA-MRSA that was used
meets all of the proposed mandatory criteria.
All isolates of S. aureus were tested for antibiotic suscepti-
bility using Vitek 2 (bioMerieux-Vitek, Hazelwood, MO,
USA). NM-MRSA was deﬁned as MRSA resistant to two or
fewer non-b-lactam antibiotics [3]. Mupirocin susceptibility
was tested by disk diffusion using a CLSI inoculum, with
interpretation of disk zones based on the criteria of Finlay
et al. [15,16]. The identity of isolates was determined by
real-time PCR assays for mec and nuc, and kinetic PCR for
single-nucleotide polymorphism (SNP) genotyping was con-
ducted using Sybr Green (Invitrogen Life Technologies,
Carlsbad, CA, USA), as described by Huygens et al. [17]. The
method uses a set of eight SNPs (arcC210, tpi241/3, arcC162,
gmk318, pta294, tpi36, pta383) derived from the multilocus
sequence typing (MLST) database that is highly predictive of
major clonal complexes (CCs) or sequence types (STs)
[17,18]. The relationship of SNP proﬁles to the population
structure of S. aureus as deﬁned by MLST is available at
http://www.ihbi.qut.edu.au/research/cells_tissue/phil_giffard/.
The identity of ST93 was conﬁrmed using a speciﬁc SNP,
aroE252. Isolates were tested for the PVL genes by real-time
PCR as described previously [17]. MLST was performed on
selected isolates as speciﬁed by Enright et al. [19]. Isolates
that underwent MLST were those that did not ﬁt a speciﬁc
CC or ST on SNP typing, comprising <1% of the S. aureus
isolates that we have typed [17]. Additionally, the prevalence
of CCs and singletons among these carriage strains of MSSA
was compared with that among clinical strains of MSSA from
a clinical cohort study of S. aureus infection conducted in the
same region from June 2004 to February 2005 [4] (Table 4).
Statistical computations of CIs for proportions and of
ORs for groups of subjects were performed using the Vas-
sarStats website (http://faculty.vassar.edu/lowry/Vassar-
Stats.html). Probabilities were calculated using the Yates chi-
squared and the Fisher exact tests. Unconditional logistic
regression analysis of potentially predictive variables was
undertaken with EPI INFO version 3.4 (Centers for Disease
Control and Prevention, Atlanta, Georgia, USA).
Results
Enrolments included 396 participants from general medical
practices (199 from Carindale Medical Centre and 197 from
Inala Health Centre General Practice) and 303 from the elec-
toral roll (153 from Carindale and 150 from Inala), a total of
699 participants. Demographics of participants are presented
in Table 1. The age range of participants was 18–96 years,
with a median age of 53 years; 293 (42%) of the subjects
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were male. The ethnicities of participants were as follows:
572 Caucasian (82%), 13 Asian (2%), 102 Aboriginal/Torres
Strait Islander (15%), and four Polynesian/Maori (0.6%). Four
hundred and eighteen participants (60%) were assessed as
having no healthcare risk factors.
The results of univariate analysis of the factors associated
with S. aureus nasal carriage are shown in Table 1. Overall,
202 (28.9%) of the subjects were S. aureus carriers. The car-
riage rate was lower in females (24.6%) than in males (34.8%,
OR 1.63, p 0.004). The carriage rate progressively declined
with increasing age, with young adults (18–39 years) having a
signiﬁcantly higher carriage rate than those aged 59 years or
older (34.4% vs. 23.1%; OR 1.74, p 0.009). There were no
signiﬁcant differences in carriage rates between electoral roll
participants and general practice participants, and no differ-
ences between those with and those without healthcare risk
factors. A history of either antibiotic exposure or boils or
other skin infections within the last 12 months did not signif-
icantly affect carriage rates. Participants from Inala, a rela-
tively economically impoverished Brisbane suburb (median
weekly income per inhabitant of US$150), had a signiﬁcantly
lower rate of nasal carriage than those from Carindale, a
suburb with a higher median weekly income of US$380
(24.8% vs. 33.0%; OR 0.67, p 0.02). The carriage rate among
Aboriginal/Torres Strait Islanders was 17.6%, signiﬁcantly
lower than that among Caucasians (31.5%; OR 2.14,
p 0.006).
Table 2 shows the results of the multivariate logistic
regression analysis for the association of S. aureus carriage
and the variables age group, ethnicity, sex and location (sub-
urb). This conﬁrmed the univariate analysis results showing
that nasal S. aureus carriage was associated with young adult
age group, Caucasian ethnicity (as compared to Aboriginal/
Torres Strait Islander ethnicity) and male sex, and that this
TABLE 1. Demographic and clinical features of study participants and their relationship to Staphylococcus aureus nasal carriage
rate
Participant group Number
Number with
positive
nasal swab
for S. aureus
Proportion of p
articipants with
S. aureus nasal
carriage (%)
95%
CI (low)
95% CI
(high) OR
p
(two-tailed)
All participants 699 202 28.9 25.7 32.4 – –
General practice participants 396 106 26.8 22.7 31.3 0.78 0.178
Electoral roll participants 303 96 31.7 26.7 37.1 – –
Caucasian ethnicity 572 180 31.5 27.8 35.4 2.14 0.006
Aboriginal/Torres Strait Islander ethnicity 102 18 17.6 11.5 26.2 – –
Other ethnicity 25 4 16.0 6.4 34.7 – –
Male 293 102 34.8 29.6 40.4 1.63 0.004
Female 406 100 24.6 20.7 29.1
Age 18–39 years 192 66 34.4 28 41.4 1.17a 0.470
Age 40–59 years 239 74 31.0 25.4 37.1
Age >59 years 268 62 23.1 18.5 28.5 1.74b 0.009
Subjects without healthcare risk factorsc 418 121 29.0 24.8 33.5 1.01 1
Subjects with healthcare risk factorsc 281 81 28.8 23.9 34.4
Subjects from Inalad 347 86 24.8 20.5 29.6 0.67 0.02
Subjects from Carindalee 352 116 33.0 28.3 38.0
Antibiotics in last 12 months (self-reported) 268 72 26.9 21.9 32.5 0.85 0.39
No antibiotics in last 12 months (self-reported) 431 130 30.2 26.0 34.7
Boils or other skin infections in last 12 months 50 13 26.0 15.9 39.6 0.86 0.75
No boils or other skin infections in last
12 months
649 189 29.1 25.8 32.7
a40–59 vs. 18–39 years.
b>59 vs. 18–39 years.
cDeﬁned as hospitalization, surgery, dialysis, healthcare occupation or residence in a long-term-care facility (nursing home, hostel, or prison) in the previous 12 months, or
the presence of a permanent indwelling catheter or percutaneous medical device.
dMedian weekly income per inhabitant US$150 (Source: 2001 Australian population census, Australian Bureau of Statistics, http://www.censusdata.abs.gov.au).
eMedian weekly income per inhabitant US$380 (Source: 2001 Australian population census, Australian Bureau of Statistics, http://www.censusdata.abs.gov.au).
TABLE 2. Unconditional multivariate logistic regression of the association of Staphylococcus aureus nasal carriage with the
variables age group, ethnicity, sex and suburb
Variable OR 95% CI Standard error Z-statistic p-Value
Age group (18–39 years vs. >59 years) 2.5170 1.5863–3.9938 0.2355 3.9189 0.0001
Age group (40–59 years vs. >59 years) 1.6536 1.0941–2.4993 0.2107 2.3869 0.0170
Ethnicity (Caucasian vs. Aboriginal/Torres St Islander) 2.6338 1.4082–4.9262 0.3195 3.0315 0.0024
Ethnicity (other vs. Aboriginal/Torres St Islander) 0.9681 0.2863–3.2743 0.6217 )0.0521 0.9585
Male 1.8069 1.2812–2.5481 0.1754 3.3729 0.0007
Location (suburb of Inala vs. suburb of Carindale) 0.8836 0.6058–1.2889 0.1926 )0.6422 0.5207
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was independent of the other variables. Although, according
to univariate analysis, there was a higher rate of nasal car-
riage of S. aureus in the suburb of Carindale than in the more
economically impoverished suburb of Inala, patients from
Inala were older and were also much more likely to be of
Aboriginal/Torres Strait ethnicity. Hence, according to multi-
variate analysis, there were no signiﬁcant differences
between the two suburbs after the factors of age and ethnic-
ity were taken into account.
One hundred and ninety-one of the 202 isolates of
S. aureus were available for genotyping, and were divided into
18 SNP proﬁles corresponding to 16 CCs or STs (some
CCs correspond to more than one SNP proﬁle) (Table 3).
All ﬁve MRSA isolates were non-multiresistant, and had SNP
proﬁles corresponding to CC5 (two isolates), CC509 (two
isolates) and ST93 (one isolate). Two isolates of NM-MRSA
were community-associated (ST93 and CC5), and three
were isolated from participants with healthcare risk factors
(CC5 and two isolates of CC509). The ST93 NM-MRSA iso-
late was positive for PVL, which is characteristic of the
Queensland clone of CA-MRSA [1,5]. The only other PVL-
positive isolate of S. aureus in the study was methicillin-sus-
ceptible and also corresponded to ST93. Both PVL-positive
isolates were from Aborigines. Only one MRSA isolate (pro-
ﬁle CGATTACA, CC5) was resistant to a non-b-lactam
(erythromycin). All isolates of S. aureus in this study were
mupirocin-susceptible.
Two MRSA isolates from Caucasians aged 55 and 85 years,
living at the same Inala address, belonged to SNP proﬁle
CGGTTCCA. None of the strains of S. aureus associated
with this SNP proﬁle in Australia had previously been noted
to be methicillin-resistant [16,19]. MLST of these isolates
revealed two new STs, which varied at one locus, new
(ST12-like): 1, 3, 1, 8, 11, new (5-like), new (11-like), and
new (ST12-like): 1, new (3-like), 1, 8, 11, new (5-like), new
(11-like).
Table 4 shows a comparison of the 186 MSSA genotypes
from this nasal carriage study with MSSA genotypes of 168
isolates associated with clinical infections in adults from a
study also conducted in southeast Queensland [4]. CC30
was signiﬁcantly over-represented among nasal carriage iso-
lates, whereas ST93 was signiﬁcantly under-represented.
CC15 and CC45 were also over-represented among carriage
isolates, but neither was statistically signiﬁcant. If healthcare-
associated strains were excluded by removing clinical isolates
from patients admitted to hospital for more than 48 h, the
signiﬁcant differences were maintained for CC30 and ST93,
but not for CC15 (data not shown).
PVL was detected in only one of 186 MSSA isolates and
one of ﬁve NM-MRSA isolates, both belonging to ST93. This
is in marked contrast to the prevalence of 16% in MSSA and
of 55% in NM-MRSA as seen in the clinical cohort [4].
Discussion
The nasal carriage rate of MRSA in volunteers from two
Brisbane suburbs is currently low, at 5/699 (0.7%), and only
TABLE 3. Single-nucleotide polymorphism (SNP) genotyping
proﬁles and multilocus sequence typing correlations of
186 methicillin-susceptible Staphylococcus aureus (MSSA)
and ﬁve methicillin-resistant S. aureus (MRSA) nasal carriage
isolates
SNP proﬁle Correlation mecA pvl
Number with proﬁle
MSSA NM-MRSA
CGAATCCA CC45 ) ) 1
CGATAACA CC5 ) ) 26
CGATAACT CC1 ) ) 5
CGATTACA CC5 ) ) 34
CGATTACA CC5 + ) 2
CGATTACT CC20 ) ) 4
CGATTCCA CC72 ) ) 1
CGGATCCA CC45 ) ) 20
CGGTAACA CC25 ) ) 1
CGGTTACA CC22 ) ) 3
CGGTTCCA CC509 ) ) 5
CGGTTCCA CC509 + ) 2
TGATAACA CC8 ) ) 1
TGATAACT CC9 ) ) 1
TGATACCA CC8 ) ) 11
TGATTACA CC78 ) ) 22
TGATTACT CC1 ) ) 6
TGATTCCA ST629 ) ) 8
TGGATCCA CC30 ) ) 36
TGGTTCTA ST93 ) + 1
TGGTTCTA ST93 + + 1
NM-MRSA, non-multiresistant S. aureus; CC, clonal complex; ST, sequence type.
TABLE 4. Comparison of distribution of clonal complexes
(CCs) and sequence types (STs) in clinical and nasal
carriage isolates of Staphylococcus aureus
Clone
Carriage
S. aureus
cohort (%)
(n = 186)
Clinical
S. aureus
cohort (%)
(n = 168)a OR p-Value
CC30 36 (19.4) 16 (9.5) 0.4 0.01b
CC45 21 (11.3) 12 (7.1) 0.4 0.07b
CC15 26 (14.0) 12 (7.1) 0.5 0.06b
CC78 22 (11.8) 17 (10.1) 0.8 0.7b
CC8 12 (6.5) 11 (6.5) 1.0 0.9b
CC5 34 (18.3) 31 (18.5) 1.0 0.9b
CC1 11 (5.9) 17 (10.1) 1.8 0.2b
ST93 1 (0.5) 10 (6.0) 11.7 0.004c
Other 23 (12.4) 45 (26.8) – –
aThis was a study of clinical isolates of S. aureus performed in the same geo-
graphical region [4].
bYates chi-squared test.
cFisher exact two-tailed test.
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two study participants (0.3%) had CA-MRSA nasal carriage.
This low prevalence of nasal carriage contrasts with a 13%
prevalence of CA-MRSA in the same region in clinical iso-
lates, more than 90% of which were from adults [3]. Chil-
dren are known to have a high incidence of CA-MRSA
infections [5], but the present study did not include children,
primarily because only adults are listed on the electoral roll
and, for the general practice component of the study, it was
difﬁcult to recruit children. The unexpectedly low carriage
rate of the predominant clone of CA-MRSA that causes clini-
cal infections in Brisbane, the ST93 PVL-positive Queensland
clone, is particularly noteworthy [3,4]. There are several
possible explanations for the discrepancy between the car-
riage rate and clinical prevalence of CA-MRSA in this region.
The ﬁrst is that the epidemiology of CA-MRSA strains may
be different to that of other strains of S. aureus. The most
important reservoir of S. aureus carriage is the nasopharynx
[8], but perhaps this is not the case for CA-MRSA strains
[20]. Other sites that could be important reservoirs of CA-
MRSA carriage include the gastrointestinal tract [21], and
household pets are also important reservoirs [22]. Another
study showed that the throat was an important site of MRSA
carriage [23], although the majority of patients in this study
had healthcare-associated strains of MRSA. An alternative
explanation for the relatively low carriage rates of CA-MRSA
strains, as compared to MSSA strains, is the higher likelihood
of progression to clinical disease with CA-MRSA strains,
resulting in earlier antibiotic treatment and eradication. This
is supported by a study showing that soldiers who were
nasal carriers of CA-MRSA strains, who were followed longi-
tudinally over an 8–10-week period, had a 10.7-fold greater
risk of clinical infection than nasal carriers of MSSA strains
[9].
The nasal carriage rate of all strains of S. aureus (methicil-
lin-susceptible and methicillin-resistant) in this community-
based adult study was 202/699 (28.9%), a rate similar to that
found in other community-based studies [24,25]. Carriage
rates were signiﬁcantly lower in women and in older adult
age groups, and these ﬁndings conﬁrm others [8,26,27]. This
study also revealed that carriage rates were lower in Aborig-
inal/Torres Strait Islanders, and others have found that peo-
ple with non-Caucasian ethnicities, e.g. Mexicans, Hispanics
and New Guinea Highlanders, have lower rates of S. aureus
nasal carriage than do Caucasians [26,28].
The study showed that baseline resistance to mupirocin of
nasal isolates is negligible in a community without signiﬁcant
pre-exposure to mupirocin. In Australia, nasal mupirocin
ointment is not approved for Pharmaceutical Beneﬁts Sche-
dule funding (a national scheme that subsidises the cost of
medically prescribed drugs), and topical mupirocin ointment
has a restricted Pharmaceutical Beneﬁts Schedule listing.
Hence, use of mupirocin nasal ointment is rare in a commu-
nity setting. The ﬁnding of negligible baseline mupirocin resis-
tance was gratifying, as mupirocin is recommended as part of
the eradication therapy for recurrent staphylococcal skin
infection, particularly for the newly emerging CA-MRSA
strains [29].
Only one of 186 carriage isolates of MSSA in this study
had detectable PVL. Clinical MSSA isolates in the same geo-
graphical region have a much higher incidence of PVL, with a
recent study showing a 16% PVL detection rate in MSSA [4].
This is in keeping with the ﬁndings of a Dutch cohort study
[30]. There was also differential prevalence of CC30, CC45,
CC15 and ST93 in carriage and in clinical isolates. Over-rep-
resentation of CC45 among carriage isolates has been
reported previously [30,31]. However, the under-representa-
tion of CC30 was unexpected, as it has previously been
reported as being over-represented in invasive strains [31].
This discrepancy may be explained in part by the inclusion of
non-invasive infections in the present clinical collection. ST93
is a strain unique to Australia, with a high prevalence of PVL
gene carriage [3,4]. Its under-representation among carriage
isolates is striking. Another study found that CA-MRSA car-
riage isolates have much lower rates of PVL carriage than do
clinical CA-MRSA isolates, although strain types of CA-MRSA
differed greatly between clinical and carriage isolates [32]. At
face value, these ﬁndings support the hypothesis that clinical
strains of S. aureus are more virulent than carriage strains,
by virtue of possessing virulence factors such as PVL. How-
ever, S. aureus is highly clonal, and horizontal spread of a
wide variety of accessory genes is well described. Therefore,
confounding cannot be discounted. It should also be men-
tioned that the role of PVL in the virulence of staphylococcal
infection is controversial and has recently been questioned
[33].
This study shows that, despite the emergence of CA-
MRSA infection as a cause of signiﬁcant morbidity and mor-
tality in southeast Queensland, the incidence of nasal carriage
of CA-MRSA strains in the general community is low. Fur-
ther studies in other populations are planned, to assess the
relative importance of nasal carriage of CA-MRSA strains as
compared to other carriage sites.
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